IPCALAB
NIFTY500
Ipca Laboratories Ltd.
Pharma · NSE
₹1,552.60
1Y+12.0%
52-week range
₹1,252 – ₹1,624
From 52w high
-4.4%
RSI (14)
59.5
vs SMA 50 / 200
↑ 50 · ↑ 200
PE
42.8
Forward PE
28.4
ROE
—
Profit margin
9.6%
D/E
14.43
Dividend yield
0.26%
Quality score
41/100
Revenue growth
6.6%
Earnings growth
23.6%
For informational purposes only. Not investment advice. VivaTrades is not a SEBI-registered Investment Adviser or Research Analyst. Market data sourced from public feeds; consult a registered adviser before any investment decision.